アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News Release

rss
2021.2.19
News Release Prof. Taiichi Sakamoto at CHIBA INSTITUTE TECHNOLOGY and TAGCyx ANNOUNCES THE RESEARCH COLLABORATION of THE STRUCTURAL ANALYSIS OF XENOLIGO®
2020.11.25
News Release SBI Pharmaceuticals and TAGCyx ANNOUNCES THE RESEARCH AND DEVELOPMENT COLLABORATION OF INOVATIVE CANCER THERAPY
2020.11.17
News Release Showa Denko Materials and the Drug Development Startup TAGCyx Sign a Commissioned Development Agreement on Regenerative Medicine Technologies
2020.9.18
News Release TAGCyx announces a research collaboration with CAGE Bio Inc. for autoimmune skin diseases.
2020.5.5
News Release TAGCyx raises approximately 200 million JPY
2020.2.19
News Release TAGCyx and GC Pharma has entered into collaborative research and development for conducting various pre-clinical studies of TAGX-0004
2019.12.25
News Release TAGCyx receives milestone payment for collaborative research with HEALIOS K.K.
2019.10.10
News Release TAGCyx enters into a collaborative aptamer glycosylation research agreement with GlyTech, Inc.
2019.10.9
News Release TAGCyx has executed a collaborative antibody-aptamer conjugate research agreement with Chiome Bioscience Inc.
2018.9.28
News Release TAGCyx has executed collaborative research agreement with HEALIOS K.K.
2018.4.29
News Release Completion of 500 million JPY Series B financing
2017.2.1
News Release TAGCyx has executed a research and development collaboration agreement with a European biopharma company in February. The partnership will continue for 2 years which is extendable with mutual agreement and will apply the TAGcyx platform towards the identificatio